Norovirus is a highly contagious RNA virus that causes sudden-onset vomiting and diarrhea, typically lasting one to three days in otherwise healthy people. It is the leading cause of acute gastroenteritis worldwide, responsible for an estimated $4.2 billion in direct health-system costs and over $60 billion in broader societal costs each year.1PLOS ONE. Global Economic Burden of Norovirus Gastroenteritis Sometimes called the “stomach flu” (though it has nothing to do with influenza), norovirus is remarkably easy to catch, stubbornly hard to kill on surfaces, and resistant to many common disinfectants. Understanding how the virus works, who it hits hardest, and what actually helps during an infection matters more than most people realize.
How Norovirus Spreads
Norovirus spreads through several routes: direct contact with an infected person, contaminated food or water, contaminated surfaces, and even tiny airborne droplets generated during vomiting.2PubMed Central. Aerosol Transmission of Norovirus That last route catches many people off guard. When someone vomits from norovirus, aerosolized particles can settle on nearby surfaces or be inhaled by bystanders, which partly explains why outbreaks rip through enclosed settings so quickly. Cruise ships, nursing homes, schools, and hospitals are classic outbreak environments because large numbers of people share close quarters, dining areas, and restrooms.3PubMed Central. Emergence of New Norovirus Variants on Spring Cruise Ships and Prediction of Winter Epidemics
The virus is also extraordinarily infectious at low doses. A tiny number of viral particles can be enough to start an infection, which is why a single case at a restaurant or a daycare can quickly spiral into dozens. Contaminated food, especially raw shellfish harvested from sewage-affected waters, leafy greens, and ready-to-eat items handled by an infected worker, accounts for a substantial share of outbreaks. Waterborne transmission through contaminated drinking or recreational water rounds out the major pathways.
Symptoms and How Quickly They Appear
The hallmark symptoms are sudden, forceful vomiting and watery diarrhea. Abdominal cramps, nausea, and low-grade fever often accompany them.4PubMed Central. Incubation periods of viral gastroenteritis: a systematic review Some people report muscle aches and headache. Vomiting tends to be the more prominent symptom in children, while adults may experience more diarrhea, though there is considerable overlap.
The incubation period — the time between swallowing the virus and feeling sick — is short. A systematic review pooling data from thousands of cases estimated a median incubation period of about 1.2 days, with most people developing symptoms somewhere between half a day and two and a half days after exposure.4PubMed Central. Incubation periods of viral gastroenteritis: a systematic review How large a dose of virus you swallow matters: experimental challenge studies found that higher inoculum doses shortened the incubation period, in some cases cutting it roughly in half.5PubMed Central. Effect of Norovirus Inoculum Dose on Virus Kinetics, Shedding, and Symptoms
For most healthy adults and older children, the illness resolves within one to three days. The classic criteria used to identify norovirus outbreaks include a mean illness duration of 12 to 60 hours and vomiting in at least half of cases.4PubMed Central. Incubation periods of viral gastroenteritis: a systematic review That brevity is deceptive, though. The acute phase can be intensely miserable, and dehydration is the primary danger, especially at the extremes of age.
What the Virus Actually Does Inside You
Norovirus belongs to the Caliciviridae family. It is a non-enveloped, single-stranded RNA virus with a genome roughly 7.5 to 7.7 kilobases long.6Europe PMC / PMC Central. Structure and Genotypes of Noroviruses Being non-enveloped is one reason it is so hard to kill: the fatty outer layer that enveloped viruses rely on (and that soap and alcohol dissolve easily) simply is not there. Norovirus has a tough protein shell instead.
Once swallowed, the virus targets specific cells in the lining of the small intestine. Research on human tissue samples has found that norovirus preferentially infects enteroendocrine cells, a specialized type of gut epithelial cell. On average, roughly 12% of enteroendocrine cells in an infected area showed evidence of active viral infection in biopsy studies.7Nature Communications. Human norovirus targets enteroendocrine epithelial cells in the small intestine These cells are significant because they are among the gut’s major producers of serotonin, a neurotransmitter that controls smooth muscle contractions throughout the digestive tract.
When norovirus infects enteroendocrine cells, it appears to trigger abnormal serotonin release and disrupts the coordinated muscle movements that normally propel food forward. Research using zebrafish models showed that norovirus infection caused prolonged and uncoordinated intestinal contractions, essentially scrambling the gut’s motility.8PLOS Pathogens. Human norovirus disturbs intestinal motility and transit time through its capsid proteins This disruption may also involve delayed gastric emptying (gastroparesis), in which the stomach fails to move its contents along on schedule. That backup is believed to contribute heavily to the intense vomiting that characterizes norovirus illness.9PubMed Central. Norovirus-induced Gastroparesis In rare cases, norovirus-triggered gastroparesis can persist well beyond the acute infection.
Treatment and Recovery
There is no antiviral drug that targets norovirus and no specific medication to shorten the illness. Treatment is entirely supportive, which in practice means replacing fluids and electrolytes lost through vomiting and diarrhea. Clinical guidelines recommend oral rehydration as the first line of treatment for most cases, with intravenous fluids reserved for people who are severely dehydrated or unable to keep fluids down.10Open Forum Infectious Diseases. Health Care Utilization and Clinical Management of All-Cause and Norovirus-Associated Acute Gastroenteritis Within a US Integrated Health Care System
Real-world data suggest these guidelines are underused. In one surveillance study, only about half of patients reported using oral rehydration during their illness, and about one in ten received IV fluids. Antibiotics are not appropriate for norovirus, since it is a virus, not a bacterial infection, yet they sometimes get prescribed during the early confusion of acute gastroenteritis.10Open Forum Infectious Diseases. Health Care Utilization and Clinical Management of All-Cause and Norovirus-Associated Acute Gastroenteritis Within a US Integrated Health Care System
For most people, the practical advice is straightforward: sip small amounts of water, clear broth, or an electrolyte drink frequently rather than trying to gulp large volumes at once. Avoid sugary sodas and fruit juice, which can worsen diarrhea. Ease back into food with bland items when you can tolerate them. If symptoms persist beyond three days, if there is blood in the stool, or if you cannot keep any fluids down for an extended period, seek medical attention.
Who Faces Serious Complications
Norovirus is unpleasant for healthy adults but genuinely dangerous for certain groups. Young children and elderly adults are the most vulnerable to dehydration because their fluid reserves are smaller and their ability to compensate is limited. Nursing home outbreaks are common among elderly populations and carry real hospitalization and mortality risk.11PubMed. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010
People with weakened immune systems face a different problem altogether. While a normal infection clears in days, immunocompromised individuals can develop chronic norovirus infection lasting weeks, months, or even years.12PubMed Central. Norovirus infection in immunocompromised hosts A systematic review found strong evidence for chronic diarrhea in immunocompromised patients, with the duration ranging from four weeks to as long as nine years. About a third of reported chronic cases led to significant weight loss or failure to thrive.13PubMed. Chronic sequelae and severe complications of norovirus infection: A systematic review of literature Among children who had received intestinal transplants, viral shedding lasted a median of 78 days, with some shedding virus for nearly a year.14PubMed. Severity and outcome of the norovirus infection in children after intestinal transplantation
Other complications with substantial evidence include necrotizing enterocolitis in premature infants and benign infantile convulsions associated with gastroenteritis.13PubMed. Chronic sequelae and severe complications of norovirus infection: A systematic review of literature These are not common outcomes in the general population, but they underscore that norovirus is not universally a mild illness.
Why Alcohol Hand Sanitizer Is Not Enough
One of the most practical misconceptions about norovirus is that a squirt of hand sanitizer will protect you. Alcohol-based sanitizers work well against enveloped viruses like influenza by dissolving their lipid membrane. Norovirus has no lipid membrane. Research testing ethanol and isopropanol against multiple norovirus strains found that their effectiveness varied dramatically by strain. In one study, 70% ethanol reduced viral loads of some GII.4 variants by nearly two log units (a roughly 99% reduction), but had almost no measurable effect on other variants of the same genotype.15PubMed Central. Strain-Specific Virolysis Patterns of Human Noroviruses in Responses to Alcohols Another study found that ten-minute exposures of GII.4 norovirus to ethanol at concentrations ranging from 10% to 70% produced less than a one-log reduction in viral genetic material.16Food Control. Efficacy of chemical disinfectant compounds against human norovirus
What does work? Sodium hypochlorite, better known as household bleach. The same study found that a ten-minute treatment with bleach at 1,000 parts per million produced a roughly 2.45 log reduction, and even 500 ppm achieved meaningful disinfection.16Food Control. Efficacy of chemical disinfectant compounds against human norovirus Hydrogen peroxide, quaternary ammonium compounds (the active ingredient in many “antibacterial” surface sprays), and iodine were all ineffective. The takeaway for your home: during and after a norovirus illness, clean contaminated surfaces with a dilute bleach solution. And wash your hands with soap and water rather than relying on sanitizer. Soap does not kill the virus, but the mechanical action of washing physically removes it from skin.
Genetic Resistance and the Secretor Gene
Not everyone who is exposed to norovirus gets sick, and genetics plays a surprisingly large role. The virus latches onto sugar molecules called histo-blood group antigens on the surface of gut cells. Whether your cells display those particular sugars depends largely on a gene called FUT2, which encodes an enzyme called fucosyltransferase 2. People with a functional copy of FUT2 are called “secretors,” and they make up roughly 70% to 80% of the population. Non-secretors, who lack functional FUT2, are highly resistant to infection by many norovirus strains.17PubMed Central. Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population
The numbers are striking. In a US pediatric study, children with norovirus gastroenteritis were 2.8 times more likely to be secretors than norovirus-negative controls. Every single one of the 155 confirmed GII.4 cases in that study, plus all 21 asymptomatic infections with GII.4, occurred in secretors.17PubMed Central. Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population Lab work using stem-cell-derived human intestinal tissue confirmed this: GII.4 norovirus replicated in tissue from secretor donors but failed to infect tissue from non-secretors. Restoring FUT2 function in non-secretor tissue made it susceptible again, demonstrating that the gene’s product is genuinely the gatekeeper.18PubMed Central. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection
Even among secretors, disease severity varies. A study of hospitalized children in Taiwan found that norovirus-infected secretors experienced significantly more vomiting, longer diarrhea, and higher overall disease severity scores than the handful of infected non-secretors.19PubMed. Clinical significance of the fucosyltransferase 2 (FUT2) secretor status in children hospitalized with acute gastroenteritis in Taiwan If you are someone who seems to dodge stomach bugs that flatten everyone around you, your FUT2 status could be why. That said, non-secretor resistance is not absolute for every norovirus genotype, and a few strains can infect non-secretors through alternative pathways.
How Long Does Immunity Last
Getting through a bout of norovirus does confer some protection, but it is not permanent. Modeling studies have estimated that immunity to norovirus gastroenteritis lasts somewhere between about four and nine years, depending on the assumptions used.20PubMed Central. Duration of Immunity to Norovirus Gastroenteritis That is longer than many people expect for a “stomach bug,” but it comes with caveats.
Norovirus is genetically diverse, classified into more than ten genogroups, and the dominant strains shift over time.21Emerging Infectious Diseases. Emergence of Novel Norovirus GII.4 Variant The GII.4 genotype causes the majority of illnesses worldwide, but new GII.4 variants emerge periodically with changes in the surface-exposed regions of their capsid protein. These antigenic shifts can allow a new variant to evade immune responses built up against the previous one, functioning somewhat like the antigenic drift seen in influenza.22PubMed Central. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains A GII.4 variant called Sydney 2012 has circulated at high levels for over a decade while accumulating amino acid changes in its antigenic regions, raising questions about whether ongoing molecular evolution could eventually produce enough change to constitute a functionally new variant.23PubMed Central. Molecular Evolution of GII.P31/GII.4_Sydney_2012 Norovirus over a Decade in a Clinic in Japan
Animal studies have also shown that the quality of immune protection varies by strain. In mouse norovirus experiments, one strain induced robust protection against both itself and a related strain, while a different strain induced only weak protection even against itself.24PLoS Pathogens. Identification of Immune and Viral Correlates of Norovirus Protective Immunity through Comparative Study of Intra-Cluster Norovirus Strains The practical meaning: you can absolutely catch norovirus more than once, whether because your immunity has waned, because you encounter a different genotype, or because the same genotype has shifted enough to partly escape your existing defenses.
Why There Is No Vaccine Yet
Given how common and costly norovirus is, the absence of a licensed vaccine is frustrating. Several candidates, mostly based on virus-like particles that mimic the shape of the real virus without containing infectious genetic material, have shown proof of efficacy in human challenge studies and entered clinical trials.25PubMed. Status of vaccine research and development for norovirus But the road to a broadly effective vaccine has been unusually bumpy.
The challenges are layered. The wide genetic and antigenic diversity of circulating noroviruses means a vaccine targeting one or two genotypes may not protect against others. New variants emerge regularly, raising the specter of vaccine-strain mismatch. Generating strong immune responses in the populations that need protection most, young children and the elderly, has proven difficult. And until recently, researchers lacked a reliable way to grow human norovirus in the lab, which hampered basic research and made testing potential vaccines and antivirals far harder.26PubMed Central. Norovirus Vaccines: Current Clinical Development and Challenges
That last obstacle has begun to lift. A breakthrough using human intestinal enteroids, miniature gut tissues grown from stem cells, now allows researchers to cultivate multiple human norovirus strains in the lab for the first time.27PubMed Central. Insights into human norovirus cultivation in human intestinal enteroids This enteroid culture system has become the most widely distributed platform for studying norovirus biology and screening potential treatments.28PubMed Central. Human norovirus cultivation systems and their use in antiviral research It is not an exaggeration to say that for nearly fifty years, the inability to grow human norovirus in culture was the single biggest barrier to understanding it. With that barrier lowered, antiviral research and vaccine testing have accelerated considerably, though a licensed product is still likely years away.
Norovirus in Animals and the Question of Cross-Species Spread
Norovirus is not exclusively a human problem. Related noroviruses infect a wide range of animals, including pigs, cattle, dogs, cats, marine mammals, and bats.29PubMed Central. Animals as Reservoir for Human Norovirus Some animal noroviruses are genetically close to human strains, which has led researchers to investigate whether the virus can jump between species.
The evidence is concerning, if preliminary. Surveillance of pig herds in Canada detected the human GII.4 Farmington Hills norovirus variant in pig fecal samples alongside typical swine norovirus genotypes. The same human GII.4 variant was also found in dairy cattle on Canadian farms.30Emerging Infectious Diseases. Human Noroviruses in Swine and Cattle These findings raise two possibilities: that human norovirus strains can transfer to livestock (and potentially back), and that co-infection of an animal with both a human and an animal norovirus strain could lead to genetic recombination, potentially producing a new virus with different properties. This is still largely a theoretical concern, and no confirmed outbreak has been traced to an animal-to-human transmission event. But it represents a gap in understanding, particularly regarding where newly emerging human norovirus variants originate.
Detecting Norovirus
Most cases of norovirus gastroenteritis are never formally diagnosed. The illness is short, self-limiting, and usually managed at home. When laboratory confirmation is needed, typically in outbreak investigations or hospitalized patients, molecular methods are the standard. Real-time reverse transcription PCR (RT-PCR) can detect and quantify norovirus genetic material in stool samples with high sensitivity, picking up viral loads spanning many orders of magnitude.31PubMed Central. Detection of Norovirus genogroup I and II by multiplex real-time RT- PCR using a 3′-minor groove binder-DNA probe Multiplex versions of these assays can identify both major genogroups (GI and GII) in a single reaction, cutting laboratory costs and turnaround time.32PubMed. Multiplex real time RT-PCR for the detection and quantitation of norovirus genogroups I and II in patients with acute gastroenteritis
For most people who catch norovirus at home, though, formal testing is unnecessary. If your symptoms match the typical pattern — sudden vomiting and diarrhea lasting a day or two, with others around you getting sick in quick succession — norovirus is the leading suspect, and treatment does not change based on a positive test. Testing matters more for public health surveillance, for identifying outbreaks in institutional settings, and for managing immunocompromised patients in whom chronic infection needs to be confirmed and monitored.
Children and Co-Infections With Other Gut Pathogens
In young children, especially in lower-resource settings, norovirus often circulates alongside other diarrheal pathogens. Stool samples from children under five with acute gastroenteritis frequently turn up more than one pathogen at a time, bacterial and viral agents together. Research in pediatric outpatient populations has found that while co-infections sometimes alter which symptoms are most prominent, they do not consistently produce more severe illness than a norovirus infection alone.33PubMed Central. Detection and Characterization of Bacterial and Viral Acute Gastroenteritis among Outpatient Children under 5 Years Old in Guangzhou, China That finding is somewhat reassuring for parents, but it also means that the presence of a second pathogen in a stool test does not automatically change how the illness should be managed. The core approach — hydration, rest, monitoring for dehydration — applies regardless.
For pediatricians, the practical significance of co-infections is mostly in avoiding unnecessary antibiotics. When both a virus and a bacterium are detected, it can be tempting to prescribe an antibiotic “just in case,” but in most outpatient cases of childhood gastroenteritis, the illness resolves without one. Antibiotics carry their own risks, including disruption of healthy gut bacteria, and guidelines consistently recommend reserving them for specific confirmed bacterial infections where they have proven benefit.